Analyst Price Target is $15.50
▲ +265.57% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for LifeMD in the last 3 months. The average price target is $15.50, with a high forecast of $16.00 and a low forecast of $15.00. The average price target represents a 265.57% upside from the last price of $4.24.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in LifeMD.
LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.